Deficiency of α-1-antitrypsin influences systemic iron homeostasis

International Journal of COPD

Volumn 8, Issue , 2013, Pages 45-51

  Ghio, Andrew J ^a   Soukup, Joleen M ^a   Richards, Judy H ^a   Fischer, Bernard M ^b   Voynow, Judith A ^b   Schmechel, Donald E ^b  

^a U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

1 antitrypsin deficiency; Ferritin; Proteinase inhibitor proteins; Serpins; Transferrin

Indexed keywords

ALPHA 1 ANTITRYPSIN; ALUMINUM; C REACTIVE PROTEIN; FERRITIN; IRON; NONHEME IRON PROTEIN; TRANSFERRIN;

ADULT; ALPHA 1 ANTITRYPSIN DEFICIENCY; ALUMINUM BLOOD LEVEL; ARTICLE; ATOMIC EMISSION SPECTROMETRY; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; HOMEOSTASIS; HUMAN; IRON BLOOD LEVEL; IRON HOMEOSTASIS; IRON METABOLISM; MALE; PROTEIN BLOOD LEVEL; SEX DIFFERENCE;

Α-1-ANTITRYPSIN DEFICIENCY; FERRITIN; PROTEINASE INHIBITOR PROTEINS; SERPINS; TRANSFERRIN;

ALPHA 1-ANTITRYPSIN; ALPHA 1-ANTITRYPSIN DEFICIENCY; ALUMINUM; C-REACTIVE PROTEIN; COPPER; FEMALE; FERRITINS; GENOTYPE; HOMEOSTASIS; HUMANS; IRON; LINEAR MODELS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; SPECTROPHOTOMETRY, ATOMIC; TRANSFERRIN;

EID: 84872927545     PISSN: 11769106     EISSN: 11782005     Source Type: Journal    
DOI: 10.2147/COPD.S37897     Document Type: Article

References (40)

1. Blanco I, Lara B, de Serres F. Efficacy of alpha1-antitrypsin augmentation therapy in conditions other than pulmonary emphysema. Orphanet J Rare Dis. 2011;6:14.
2. Lomas DA. The selective advantage of alpha1-antitrypsin deficiency. Am J Respir Crit Care Med. 2006;173(10):1072-1077.
3. Tuder RM, Janciauskiene SM, Petrache I. Lung disease associated with alpha1-antitrypsin deficiency. Proc Am Thorac Soc. 2010;7(6):381-386.
4. Stoller JK, Aboussouan LS. Alpha1-antitrypsin deficiency. Lancet. 2005;365(9478):2225-2236.
5. Luisetti M, Seersholm N. Alpha1-antitrypsin deficiency. 1: epidemiology of alpha1-antitrypsin deficiency. Thorax. 2004;59(2):164-169.
6. Marx JJ. Iron and infection: competition between host and microbes for a precious element. Best Pract Res Clin Haematol. 2002;15(2):411-426.
7. Britigan BE, Hayek MB, Doebbeling BN, Fick RB Jr. Transferrin and lactoferrin undergo proteolytic cleavage in the Pseudomonas aeruginosa-infected lungs of patients with cystic fbrosis. Infect Immun. 1993;61(12):5049-5055.
8. Miller RA, Britigan BE. Protease-cleaved iron-transferrin augments oxidant-mediated endothelial cell injury via hydroxyl radical formation. J Clin Invest. 1995;95(6):2491-2500.
9. Gardi C, Arezzini B, Fortino V, Comporti M. Effect of free iron on collagen synthesis, cell proliferation and MMP-2 expression in rat hepatic stellate cells. Biochem Pharmacol. 2002;64(7):1139-1145.
10. Shigematsu T, Fukushima J, Oyama M, Tsuda M, Kawamoto S, Okuda K. Iron-mediated regulation of alkaline proteinase production in Pseudomonas aeruginosa. Microbiol Immunol. 2001;45(8):579-590.
11. Brumlik MJ, Storey DG. Zinc and iron regulate translation of the gene encoding Pseudomonas aeruginosa elastase. Mol Microbiol. 1992;6(3):337-344.
12. Okazaki I, Brinckerhoff CE, Sinclair J F, Sinclair PR, Bonkowsky HL, Harris ED Jr. Iron increases collagenase production by rabbit synovial fibroblasts. J Lab Clin Med. 1981;97(3):396-402.
13. Stites S W, Plautz M W, Bailey K, O'Brien-Ladner AR, Wesselius LJ. Increased concentrations of iron and isoferritins in the lower respiratory tract of patients with stable cystic fbrosis. Am J Respir Crit Care Med. 1999;160(3):796-801.
14. Reid DW, Lam QT, Schneider H, Walters EH. Airway iron and iron-regulatory cytokines in cystic fbrosis. Eur Respir J. 2004;24(2):286-291.
15. Lucey EC, Stone PJ, Christensen TG, Breuer R, Snider GL. An 18-month study of the effects on hamster lungs of intratracheally administered human neutrophil elastase. Exp Lung Res. 1988;14(5):671-686.
16. Rabinovitz M, Gavaler JS, Kelly RH, Van Thiel DH. Association between heterozygous alpha 1-antitrypsin deficiency and genetic hemochromatosis. Hepatology. 1992;16(1):145-148.
17. Fischer BM, Domowicz DA, Zheng S, et al. Neutrophil elastase increases airway epithelial nonheme iron levels. Clin Transl Sci. 2009;2(5):333-339.
18. McNabb JC, Cappa JA, Ross J W. Disorders of iron metabolism associated with protease inhibitor therapy. Clin Infect Dis. 2001;33(3):413-414.
19. Alpha 1-antitrypsin deficiency: memorandum from a WHO meeting. Bull World Health Organ. 1997;75(5):397-415.
20. Jacobs EM, Hendriks JC, van Deursen CT, et al. Severity of iron overload of proband determines serum ferritin levels in families with HFE-related hemochromatosis: the HEmochromatosis FAmily Study. J Hepatol. 2009;50(1):174-183.
21. Herbert V, Jayatilleke E, Shaw S, et al. Serum ferritin iron, a new test, measures human body iron stores unconfounded by infammation. Stem Cells. 1997;15(4):291-296.
22. Powell LW, Halliday J W, Cowlishaw JL. Relationship between serum ferritin and total body iron stores in idiopathic haemochromatosis. Gut. 1978;19(6):538-542.
23. Rauscher L, Expert D, Matzanke B F, Trautwein AX. Chrysobactindependent iron acquisition in Erwinia chrysanthemi. Functional study of a homolog of the Escherichia coli ferric enterobactin esterase. J Biol Chem. 2002;277(4):2385-2395.
24. Brochu V, Grenier D, Nakayama K, Mayrand D. Acquisition of iron from human transferrin by Porphyromonas gingivalis: a role for Argand Lys-gingipain activities. Oral Microbiol Immunol. 2001;16(2):79-87.
25. Miller RA, Rasmussen GT, Cox CD, Britigan BE. Protease cleavage of iron-transferrin augments pyocyanin-mediated endothelial cell injury via promotion of hydroxyl radical formation. Infect Immun. 1996;64(1):182-188.
26. Wolz C, Hohloch K, Ocaktan A, et al. Iron release from transferrin by pyoverdin and elastase from Pseudomonas aeruginosa. Infect Immun. 1994;62(9):4021-4027.
27. Brines RD, Brock JH. The effect of trypsin and chymotrypsin on the in vitro antimicrobial and iron-binding properties of lactoferrin in human milk and bovine colostrum. Unusual resistance of human apolactoferrin to proteolytic digestion. Biochim Biophys Acta. 1983;759(3):229-235.
28. Santos JA, Gonzalez CJ, Lopez TM, Otero A, Garcia-Lopez ML. Hemolytic and elastolytic activities infuenced by iron in Plesiomonas shigelloides. J Food Prot. 1999;62(12):1475-1477.
29. Sokol PA, Cox CD, Iglewski BH. Pseudomonas aeruginosa mutants altered in their sensitivity to the effect of iron on toxin A or elastase yields. J Bacteriol. 1982;151(2):783-787.
30. Graziadei I, Kahler CM, Wiedermann CJ, Vogel W. The acute-phase protein alpha 1-antitrypsin inhibits transferrin-receptor binding and proliferation of human skin fibroblasts. Biochim Biophys Acta. 1998;1401(2):170-176.
31. Weiss G, Graziadel I, Urbanek M, Grunewald K, Vogel W. Divergent effects of alpha 1-antitrypsin on the regulation of iron metabolism in human erythroleukaemic (K562) and myelomonocytic (THP-1) cells. Biochem J. 1996;319 (Pt 3):897-902.
32. Graziadei I, Weiss G, Bohm A, Werner-Felmayer G, Vogel W. Unidirectional upregulation of the synthesis of the major iron proteins, transferrin-receptor and ferritin, in HepG2 cells by the acute-phase protein alpha1-antitrypsin. J Hepatol. 1997;27(4):716-725.
33. Graziadei I, Kaserbacher R, Braunsteiner H, Vogel W. The hepatic acute-phase proteins alpha 1-antitrypsin and alpha 2-macroglobulin inhibit binding of transferrin to its receptor. Biochem J. 1993;290(Pt 1): 109-113.
34. Graziadei I, Weiss G, Egger C, Niederwieser D, Patsch JR, Vogel W. Modulation of iron metabolism in monocytic THP-1 cells and cultured human monocytes by the acute-phase protein alpha1-antitrypsin. Exp Hematol. 1998;26(11):1053-1060.
35. Kaserbacher R, Propst T, Propst A, Graziadei I, Judmaier G, Vogel W. Association between heterozygous alpha 1-antitrypsin deficiency and genetic hemochromatosis. Hepatolog y. 1993;18(3):707-708.
36. Brunt EM, Tavill AS, Bacon BR. A 49-year-old man with alpha 1-antitrypsin deficiency and abnormal iron study results. Semin Liver Dis. 1996;16(1):97-101.
37. Ghio AJ. Disruption of iron homeostasis and lung disease. Biochim Biophys Acta. 2009;1790(7):731-739.
38. Mayer AS, Stoller JK, Bucher Bartelson B, James Ruttenber A, Sandhaus RA, Newman LS. Occupational exposure risks in individuals with PI*Z alpha(1)-antitrypsin deficiency. Am J Respir Crit Care Med. 2000;162(2 Pt 1):553-558.
39. Banauch GI, Brantly M, Izbicki G, et al. Accelerated spirometric decline in New York City frefghters with alpha-antitrypsin deficiency. Chest. 2010;138(5):1116-1124.
40. Wood AM, Harrison RM, Semple S, Ayres JG, Stockley RA. Outdoor air pollution is associated with disease severity in alpha1-antitrypsin deficiency. Eur Respir J. 2009;34(2):346-353.